Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5188093
Max Phase: Preclinical
Molecular Formula: C24H32N8O4S
Molecular Weight: 528.64
Associated Items:
ID: ALA5188093
Max Phase: Preclinical
Molecular Formula: C24H32N8O4S
Molecular Weight: 528.64
Associated Items:
Canonical SMILES: CN1CCC2(CC1)C[C@H](Nc1ncnc3c1nnn3[C@@H]1C[C@@H](COS(N)(=O)=O)[C@@H](O)C1)c1ccccc12
Standard InChI: InChI=1S/C24H32N8O4S/c1-31-8-6-24(7-9-31)12-19(17-4-2-3-5-18(17)24)28-22-21-23(27-14-26-22)32(30-29-21)16-10-15(20(33)11-16)13-36-37(25,34)35/h2-5,14-16,19-20,33H,6-13H2,1H3,(H2,25,34,35)(H,26,27,28)/t15-,16+,19-,20-/m0/s1
Standard InChI Key: CSHUTMOBESIZLB-JSJNYSNDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 528.64 | Molecular Weight (Monoisotopic): 528.2267 | AlogP: 1.27 | #Rotatable Bonds: 6 |
Polar Surface Area: 161.38 | Molecular Species: BASE | HBA: 11 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.40 | CX Basic pKa: 9.10 | CX LogP: 0.38 | CX LogD: -1.33 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.42 | Np Likeness Score: -0.24 |
1. Xiong C, Zhou L, Tan J, Song S, Bao X, Zhang N, Ding H, Zhao J, He JX, Miao ZH, Zhang A.. (2021) Development of Potent NEDD8-Activating Enzyme Inhibitors Bearing a Pyrimidotriazole Scaffold., 64 (9.0): [PMID:33857374] [10.1021/acs.jmedchem.1c00242] |
Source(1):